Oryza Sativa Recombinant HSA Freeze - Dried Powder 66.554KD Molecular Mass Human Albumin Protein

 
Oryza Sativa Recombinant Human Serum Albumin Protein HSA Freeze - Dried Powder 66.554KD Molecular Mass
 
Quick detail
 

1. CAS No.: 70024-90-7
2. Other Names: Recombinant HSA, rHSA, OsrHSA
3. EINECS No.: 274-272-6
4. Place of Origin: Wuhan, China (Mainland)
5. Storage and Handling: Stored at temperatures 2-8℃ for 48 months
6. Brand Name: Oryzogen
7. Model Number: HYC002M01
8. Purity: Greater than 99 % as determined by SDS-PAGE

 
 
Physiological and Biochemical Properties of rHSA and pHSA
 

 
 
Description
 
Human serum albumin is derived from human plasma, which is collected from different human bodies. So we can not guarantee the stability of human serum albumin from different batches. Because of this, it is difficult to apply to large-scale application in vaccine production and cell culture. Healthgen Biotech uses State-of-the-art platform rice endosperm cells as the bioreactor to express the human serum albumin. The platform have high capacity and stable storage protein body to express and storage the proteins and peptides in the rice grain.Rice endosperm cells can specifically and highly express various recombinant proteins and small peptides. By using homozygous rice as the raw material, with the world's top production process, Healthgen can maximize the stability of albumin batches to meet the needs of industrial production.
 

 

 
 
Advantages
 
1. Healthgen Biotech recombinant human serum albumin (OsrHSA) has excellent batch consistency. Using self-pollination rice as the bioreactor to express the OsrHSA, with the world's advanced facility and top production proceeding to extract and purify the OsrHSA, Healthgen Biotech can ensure the excellent consistency of OsrHSA from different batches.
 
2. The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity.
 
At present, the production capacity is almost 1000 kg / year.
 
 
Supplemental Description
 
Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech) was founded in 2006, located in Wuhan National Biological Industry Base---Wuhan BioLake. Healthgen Biotech is a collection of biotechnology, modern agriculture and bio-pharmaceutical, which is an innovative high-tech enterprises driven by the original innovation, specializing in molecular pharmaceutical research and development. Healthgen Biotech commits to provide green, safety, inexpensive and adequate biopharmaceuticals, always adhere to the original scientific and technological innovation, take the market as the orientation and depend on the national demand responsibility.